Shawn A. Scranton

Shawn A. Scranton currently works at Libra Therapeutics, Inc., as President & Chief Executive Officer from 2024.
Dr. Scranton also formerly worked at Kalypsys, Inc., as Director-Translational Medicine from 2005 to 2007, Salmedix, Inc., as Director-Clinical Research & Program from 2001 to 2005, Dura Pharmaceuticals, Inc., as Principal from 1998 to 2000, Baylor College of Medicine, as Faculty Member, Victory Pharma, Inc., as Vice President-Scientific Operations from 2007 to 2012, Pelican, Inc., as Chief Operating Officer & Senior Vice President from 2018 to 2020, Sentynl Therapeutics, Inc., as Chief Scientific Officer & Senior Vice President from 2015 to 2017, and Amber Ophthalmics, as President & Chief Scientific Officer from 2020 to 2024.
Dr. Scranton received his undergraduate degree in 1988 from the University of California San Diego and doctorate degree in 1994 from the University of the Pacific.